Bradley, Kenneth

Bradley Kenneth is a renowned expert in the field of microbiology. He has published numerous articles on various topics related to bacterial pathogens and their treatment options. His research focuses on understanding the mechanisms behind antibiotic resistance and developing new strategies for combating it.

Biography:  https://www.nature.com/articles/n35101999

66%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

80%

Examples:

  • and also in the contradictions section where they mention that CRAB has emerged as a major global pathogen with limited treatment options1.
  • The author has a clear bias towards the topic of antibiotic resistance and its impact on global health. This is evident in their choice of article title which mentions

Conflicts of Interest

50%

Examples:

  • The author does not provide any information about potential conflicts of interest related to their research or writing on antibiotic resistance and CRAB.

Contradictions

90%

Examples:

  • The author cites several studies that suggest anthrax toxin is not effective in treating CRAB. They also mention that there are no major contradictions found in the literature regarding this topic.

Deceptions

60%

Examples:

No current examples available.

Recent Articles

New Antibiotic Offers Hope Against Hospital Superbugs

New Antibiotic Offers Hope Against Hospital Superbugs

Broke On: Wednesday, 03 January 2024 Zosurabalpin is a new class of antibiotics that has been discovered after screening about 45,000 small molecules with potential antibiotic properties. In laboratory experiments, zosurabalpin stopped a critical building block - a lipopolysaccharide - being transported to the outer part of the cell, preventing the protective membrane from forming properly and ultimately leading to cell death. The compound appears to destroy the organism's ability to successfully assemble its key protective membrane.